Pioneered by the University of Kent.

The initial clinic to test the brand new instrument was at the brand new York Eye and Ear Infirmary. Since the first set up, OTI, The Applied Optics group in Kent and the Retina Research Lab in NY work together to further improve and enhance the overall performance of the technology. Dr Richard Rosen, Director of the Retinal Imaging Laboratory, was so impressed by the results that he and his researchers have been working closely with the team ever since and are currently involved with the clinical trials. The clinical investigators alongside the Kent team have jointly released in worldwide medical publications and presented at scientific and scientific conferences over 50 publications and presentations linked to this research.. A distinctive new non-invasive way of high resolution optical imaging of the optical eye A distinctive new non-invasive way of high res optical imaging of the optical eye is receiving global acclaim.Scapularis can be found, B. Miyamotoi may also be found.24 Thus, the spirochetes found in the CSF of our patient could have been any of these organisms, particularly if preliminary morphologic and antigenic analysis appeared to rule out B. Burgdorferi sensu stricto. Our case report shows that B. Miyamotoi disease is a likely cause of this case of meningoencephalitis. The disease that was observed, characterized by a progressive cognitive decline, was non-specific and might have been misdiagnosed, although it was successfully treated as a case of Lyme neuroborreliosis. However, the microscopical detection of an extraordinary density of morphologically unique spirochetes in the CSF of our individual attracted additional scrutiny.